Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Retail Industry News Fortune Brands Innovations leadership reset raises execution questions after CEO appointment Fortune Brands Innovations names a new CEO, but shares slip. Find out why investors are cautious and what the leadership change means next. byPallavi MadhirajuFebruary 15, 2026